FOXM1 and cancer: Furthermore, excluding kinase inhibitors and compounds not available for purchase, we compared the profiles of these hits with the changes in expression of established FOXM1 targets [35, 36] present in our dataset across seven cancer cell lines (A549, MCF7, VCAP, HA1E, A375, HCC515, and HT29).